Table 1.

Characteristics of the Boston and Copenhagen cohorts

	Boston	Copenhagen
	n = 190	n = 50	p
Age (years)	57 ± 12	61 ± 11	0.07
Sex (F)	117 (62%)	45 (90%)	< 0.001
WFNS	1 [1, 4]	3 [1, 4]	0.016
Modified Fisher score	3 [3, 4]	3 [3, 3]	0.25
mRS at 90 days	2 [1, 3]	1 [0, 3]	0.045
Mortality at 90 days	25 (13%)	5 (10%)	0.55
DCI*	61 (43%)	25 (50%)	0.39
Plasma sST2 (ng/mL), Day 3	75.1 [44.0, 133]	82.4 [47.8, 167]	0.73
CSF sST2 (ng/mL), Day 3**	17.1 [4.1, 44.1]	--	--

^*DCI designations were available for 142 patients in the MGH cohort

^**CSF samples were available from 46 patients in the MGH cohort